Literature DB >> 31275069

Crohn's Disease of the Esophagus, Duodenum, and Stomach.

David M Schwartzberg1, Stephen Brandstetter1, Alexis L Grucela2.   

Abstract

Upper gastrointestinal Crohn's is an under-reported, under-recognized phenotype of Crohn's disease. Routine screening in the pediatric population has shown a higher prevalence compared with adults; however, most adult patients remain asymptomatic with respect to upper gastrointestinal Crohn's disease. For the patients who are symptomatic, medical treatment is the first line of management, except for cases of obstruction, perforation, or bleeding. Though most patients respond to medical therapy, mainly steroids, with the addition of immunomodulators and more recently biologics agents, surgical intervention is usually required only for obstructing gastroduodenal disease secondary to strictures. Strictureplasty and bypass are safe operations with comparable morbidity, although bypass has higher rates of dumping syndrome and marginal ulceration in the long term. Rare cases of gastroduodenal fistulous disease from active distal disease may involve the stomach or duodenum, and esophageal Crohn's disease can fistulize to surrounding structures in the mediastinum which may require the highly morbid esophagectomy.

Entities:  

Keywords:  Upper Gastrointestinal Crohn's Disease; esophageal Crohn's disease; gastroduodenal Crohn's disease; strictureplasty

Year:  2019        PMID: 31275069      PMCID: PMC6606321          DOI: 10.1055/s-0039-1683850

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  110 in total

1.  Evaluation of Crohn disease activity with magnetic resonance imaging.

Authors:  F Maccioni; A Viscido; L Broglia; M Marrollo; R Masciangelo; R Caprilli; P Rossi
Journal:  Abdom Imaging       Date:  2000 May-Jun

Review 2.  Endoscopic therapy for multiple mucosal bridges in the esophagus of a patient with Crohn's disease.

Authors:  H Hanai; S Honda; K Sugimoto; M Kageoka; H Iwasaki; R Higuchi; Y Horio; F Watanabe; E Kaneko
Journal:  Gastrointest Endosc       Date:  1999-11       Impact factor: 9.427

Review 3.  Crohn's disease of the foregut.

Authors:  H L Reynolds; T A Stellato
Journal:  Surg Clin North Am       Date:  2001-02       Impact factor: 2.741

4.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.

Authors:  E A Vasiliauskas; L Y Kam; L C Karp; J Gaiennie; H Yang; S R Targan
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

5.  Crohn's disease of the stomach: the "ram's horn" sign.

Authors:  J Farman; D Faegenburg; S Dallemand; C K Chen
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-02

6.  A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Authors:  C Gasche; J Scholmerich; J Brynskov; G D'Haens; S B Hanauer; E J Irvine; D P Jewell; D Rachmilewitz; D B Sachar; W J Sandborn; L R Sutherland
Journal:  Inflamm Bowel Dis       Date:  2000-02       Impact factor: 5.325

7.  Application of the Vienna Classification for Crohn's disease to a single clinician database of 877 patients.

Authors:  H J Freeman
Journal:  Can J Gastroenterol       Date:  2001-02       Impact factor: 3.522

8.  Treatment of esophageal Crohn's disease by enteral feeding via percutaneous endoscopic gastrostomy.

Authors:  T S Thomas; E Berto; M L Scribano; S J Middleton; J O Hunter
Journal:  JPEN J Parenter Enteral Nutr       Date:  2000 May-Jun       Impact factor: 4.016

9.  Strictureplasty is an effective option in the operative management of duodenal Crohn's disease.

Authors:  M J Worsey; T Hull; L Ryland; V Fazio
Journal:  Dis Colon Rectum       Date:  1999-05       Impact factor: 4.585

10.  Outcome of strictureplasty for duodenal Crohn's disease.

Authors:  T Yamamoto; I M Bain; A B Connolly; R N Allan; M R Keighley
Journal:  Br J Surg       Date:  1999-02       Impact factor: 6.939

View more
  4 in total

1.  Histologically confirmed upper gastrointestinal Crohn's disease: is it rare or are we just not searching hard enough?

Authors:  Omar Ibrahim Saadah; Kholoud Bakur Fallatah; Cedric Baumann; Abdulrahman Ahmed Elbaradie; Fatimah Talat Howladar; Motaz Tariq Daiwali; Omar Hamad Alshuaibi; Majid Abdulaziz Alsahafi; Rana Yaqoob Bokhary; Yousef Abdulfattah Qari; Laurent Peyrin-Biroulet; Mahmoud Hisham Mosli
Journal:  Intest Res       Date:  2020-02-07

2.  Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients.

Authors:  Eun Sil Kim; Yiyoung Kwon; Yon Ho Choe; Mi Jin Kim
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

3.  Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Istvan Fedor; Eva Zold; Zsolt Barta
Journal:  J Clin Med       Date:  2021-12-20       Impact factor: 4.241

Review 4.  Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls.

Authors:  Bence Kővári; Rish K Pai
Journal:  Adv Anat Pathol       Date:  2022-01-01       Impact factor: 3.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.